Smith DL - Search Results

1

Natural killer cell cytolytic activity is necessary for in vivo antitumor activity of the dipeptide L-glutamyl-L-tryptophan.

Smith DL, Cai J, Zhu S, Wei W, Fukumoto J, Sharma S, Masood R, Gill PS. Smith DL, et al. Int J Cancer. 2003 Sep 10;106(4):528-533. doi: 10.1002/ijc.11253. Int J Cancer. 2003. PMID: 12845648

2

Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops.

Masood R, Kundra A, Zhu S, Xia G, Scalia P, Smith DL, Gill PS. Masood R, et al. Among authors: smith dl. Int J Cancer. 2003 May 1;104(5):603-10. doi: 10.1002/ijc.10996. Int J Cancer. 2003. PMID: 12594815

3

Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium.

Masood R, Xia G, Smith DL, Scalia P, Still JG, Tulpule A, Gill PS. Masood R, et al. Among authors: smith dl. Blood. 2005 Feb 1;105(3):1310-8. doi: 10.1182/blood-2004-03-0933. Epub 2004 Oct 7. Blood. 2005. PMID: 15471957 Free article.

4

Antineoplastic urinary protein inhibits Kaposi's sarcoma and angiogenesis in vitro and in vivo.

Masood R, McGarvey ME, Zheng T, Cai J, Arora N, Smith DL, Sloane N, Gill PS. Masood R, et al. Among authors: smith dl. Blood. 1999 Feb 1;93(3):1038-44. Blood. 1999. PMID: 9920854 Free article.

5

Kaposi sarcoma is a therapeutic target for vitamin D(3) receptor agonist.

Masood R, Nagpal S, Zheng T, Cai J, Tulpule A, Smith DL, Gill PS. Masood R, et al. Among authors: smith dl. Blood. 2000 Nov 1;96(9):3188-94. Blood. 2000. PMID: 11050002 Free article. Clinical Trial.

6

Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors.

Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS. Masood R, et al. Among authors: smith dl. Blood. 2001 Sep 15;98(6):1904-13. doi: 10.1182/blood.v98.6.1904. Blood. 2001. PMID: 11535528 Free article.

7

Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma.

Masood R, Cai J, Tulpule A, Zheng T, Hamilton A, Sharma S, Espina BM, Smith DL, Gill PS. Masood R, et al. Among authors: smith dl. Clin Cancer Res. 2001 Sep;7(9):2693-702. Clin Cancer Res. 2001. PMID: 11555581

8

Expression of EphB4 in head and neck squamous cell carcinoma.

Sinha UK, Kundra A, Scalia P, Smith DL, Parsa B, Masood R, Gill PS. Sinha UK, et al. Among authors: smith dl. Ear Nose Throat J. 2003 Nov;82(11):866, 869-70, 887. Ear Nose Throat J. 2003. PMID: 14661437

9

Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor.

Masood R, Cesarman E, Smith DL, Gill PS, Flore O. Masood R, et al. Among authors: smith dl. Am J Pathol. 2002 Jan;160(1):23-9. doi: 10.1016/S0002-9440(10)64344-1. Am J Pathol. 2002. PMID: 11786394 Free PMC article.

10

Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical efficacy.

Levine AM, Tulpule A, Quinn DI, Gorospe G 3rd, Smith DL, Hornor L, Boswell WD, Espina BM, Groshen SG, Masood R, Gill PS. Levine AM, et al. Among authors: smith dl. J Clin Oncol. 2006 Apr 10;24(11):1712-9. doi: 10.1200/JCO.2005.03.4801. Epub 2006 Mar 6. J Clin Oncol. 2006. PMID: 16520466 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,646 results

Search Page

Filters